Ironwood Pharmaceuticals | IRWD - Pendapatan Penjualan





Penjualan Perubahan Tanggal
Acadia Pharmaceuticals USD 268.06M 15.94M 2026-03
Agios Pharmaceuticals USD 18.8M 1.17M 2026-03
Akebia Therapeutics USD 57.62M 1.14M 2025-12
Almirall EUR 547.63M 12.83M 2025-12
Alnylam Pharmaceuticals USD 1.17B 70M 2026-03
Amarin USD 49.22M 451K 2025-12
Ardelyx USD 94.47M 30.74M 2026-03
Astellas Pharma JPY 537.93B 33.28B 2026-03
AstraZeneca USD 15.29B 213M 2026-03
Charles River Laboratories USD 995.8M 1.6M 2026-03
Coherus Biosciences USD 12.75M 1.18M 2025-12
Emergent BioSolutions USD 276.6M 6.1M 2023-12
Esperion Therapeutics USD 168.45M 81.14M 2025-12
Halozyme Therapeutics USD 377M 74.76M 2026-03
Incyte USD 1.27B 240M 2026-03
Ironwood Pharmaceuticals USD 106.51M 58.8M 2026-03
Karyopharm Therapeutics USD 34.08M 3.54M 2025-12
Lexicon Pharmaceuticals USD 5.49M 8.69M 2025-12
MacroGenics USD 20.8M 20.43M 2026-03
Moderna USD 389M 289M 2026-03
Myriad Genetics USD 200.4M 9.4M 2026-03
Pacira USD 177M 19.87M 2026-03
PTC Therapeutics USD 273M 108.3M 2026-03
Puma Biotechnology USD 80.54M 33.46M 2024-09
Sarepta Therapeutics USD 730.8M 287.9M 2026-03
Takeda JPY 1.09T 100B 2026-03
Ultragenyx Pharmaceutical USD 136M 71M 2026-03
Vanda Pharmaceuticals USD 198.77M 151.12M 2024-12